SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

YD Bio Ltd
Date: July 7, 2025 · CIK: 0002011674 · Accession: 0001213900-25-061831

Offering / Registration Process Regulatory Compliance Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-283428

Date
July 7, 2025
Author
ARENTFOX SCHIFF LLP
Form
CORRESP
Company
YD Bio Ltd

Letter

ArentFox Schiff LLP 1717 K Street, NW Washington, DC 20006

202.857.6000 main

202.857.6395 fax

afslaw.com

Marc Rivera

Partner

202.350.3643 direct

marc.rivera@afslaw.com

July 7, 2025

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street, NE

Washington, DC 20549

Attention: Christie Wong, Michael Fay, Jane Park and Margaret Sawicki

Re: YD Bio Limited

Amendment No. 7 to Registration Statement on Form F-4

Filed June 30, 2025

File No. 333-283428

Ladies and Gentlemen:

This letter is being submitted on behalf of YD Bio Limited (the " Company ") in response to the comment letter, dated July 3, 2025, of the staff of the Division of Corporation Finance (the " Staff ") of the Securities and Exchange Commission (the " Commission ") with respect to Amendment No. 7 to Registration Statement on Form F-4 filed on June 30, 2025 (the " Registration Statement "). Concurrently with this response, the Company has filed Amendment No. 8 to the Registration Statement on Form F-4/A pursuant to the Staff's comments (the " Amended Registration Statement ").

Smart In Your World ® July 7, 2025 Page 2

Amendment No. 7 to Form F-4 filed June 30, 2025

Exhibits

1. We note the following opinion in Exhibit 8.1: "Based on and subject to the foregoing, including, without limitation, the qualifications, exceptions and assumptions set forth above and the exceptions, qualifications and limitations set forth below, in our opinion . . . (ii) the statements of United States federal income tax law with respect to the Parent Merger on the date hereof, or the holding or disposition of Pubco shares received in connection with the Parent Merger, as set forth in the Registration Statement under the caption "Material U.S. Federal Income Tax Considerations," are accurate in all material respects," and a similar opinion appears in Exhibit 8.2: "Based on and subject to the foregoing, the qualifications, exceptions, assumptions, qualifications and limitations contained herein and in the Registration Statement, it is our opinion that . . . (ii) the statements in the Registration Statement set forth under the caption "Material U.S. Federal Income Tax Considerations," to the extent that they constitute descriptions or summaries of material U.S. federal income tax considerations attributable to the Merger or to the holding or disposition of Pubco shares received in connection with the Merger, are accurate in all material respects." The "fairness" or "accuracy" of the prospectus disclosure is not the appropriate subject of the opinion. Counsel must opine on the tax consequences of the offering, not the manner in which they are described in the prospectus. Refer to Section III.C.2 of Staff Legal Bulletin No. 19.

RESPONSE: The Company respectfully acknowledges the Staff's comment and advises the Staff that the statements noted in the Staff's comment above have been removed from the revised tax opinions filed as Exhibits 8.1 and 8.2 to the Amended Registration Statement.

* * *

* * *

July 7, 2025 Page 3

Should you have any questions regarding the foregoing, please do not hesitate to contact Marc Rivera at (202) 350-3643.

Sincerely,
ARENTFOX SCHIFF LLP

Show Raw Text
CORRESP
 1
 filename1.htm

 ArentFox Schiff LLP
 1717 K Street, NW
 Washington, DC 20006

 202.857.6000 main

 202.857.6395 fax

 afslaw.com

 Marc Rivera

 Partner

 202.350.3643 direct

 marc.rivera@afslaw.com

 July 7, 2025

 VIA EDGAR

 United States Securities and Exchange Commission

 Division of Corporation Finance

 Office of Industrial Applications and Services

 100 F Street, NE

 Washington, DC 20549

 Attention: Christie Wong, Michael Fay, Jane Park and Margaret Sawicki

 Re:
 YD Bio Limited

 Amendment No. 7 to Registration Statement on Form F-4

 Filed June 30, 2025

 File No. 333-283428

 Ladies and Gentlemen:

 This letter is being submitted
on behalf of YD Bio Limited (the " Company ") in response to the comment letter, dated July 3, 2025, of the staff of
the Division of Corporation Finance (the " Staff ") of the Securities and Exchange Commission (the " Commission ")
with respect to Amendment No. 7 to Registration Statement on Form F-4 filed on June 30, 2025 (the " Registration Statement ").
Concurrently with this response, the Company has filed Amendment No. 8 to the Registration Statement on Form F-4/A pursuant to the Staff's
comments (the " Amended Registration Statement ").

 Smart In Your World ®
 July 7, 2025 Page 2

 Amendment No. 7 to Form F-4 filed June
30, 2025

 Exhibits

 1. We note the following opinion in Exhibit 8.1: "Based on and subject to the foregoing,
 including, without limitation, the qualifications, exceptions and assumptions set forth above and the exceptions, qualifications and
 limitations set forth below, in our opinion . . . (ii) the statements of United States federal income tax law with respect to
 the Parent Merger on the date hereof,
or the holding or disposition of Pubco shares received in connection with the Parent Merger, as set forth in the Registration Statement
under the caption "Material U.S. Federal Income Tax Considerations," are accurate in all material respects," and a similar
opinion appears in Exhibit 8.2: "Based on and subject to the foregoing, the qualifications, exceptions, assumptions, qualifications
and limitations contained herein and in the Registration Statement, it is our opinion that . . . (ii) the statements in the Registration
Statement set forth under the caption "Material U.S. Federal Income Tax Considerations," to the extent that they constitute
descriptions or summaries of material U.S. federal income tax considerations attributable to the Merger or to the holding or disposition
of Pubco shares received in connection with the Merger, are accurate in all material respects." The "fairness" or "accuracy"
of the prospectus disclosure is not the appropriate subject of the opinion. Counsel must opine on the tax consequences of the offering,
not the manner in which they are described in the prospectus. Refer to Section III.C.2 of Staff Legal Bulletin No. 19.

 RESPONSE: The Company respectfully acknowledges the Staff's comment and advises the Staff that the statements
noted in the Staff's comment above have been removed from the revised tax opinions filed as Exhibits 8.1 and 8.2 to the Amended
Registration Statement.

 *	          *         	*

 * * *

 July 7, 2025 Page 3

 Should you have any questions regarding the foregoing,
please do not hesitate to contact Marc Rivera at (202) 350-3643.

 Sincerely,

 ARENTFOX SCHIFF LLP

 /s/ Marc Rivera

 By: Marc Rivera

 Enclosures